Results 191 to 200 of about 199,675 (257)
Some of the next articles are maybe not open access.

Related searches:

Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease.

Cochrane Database of Systematic Reviews, 2023
BACKGROUND Long-acting beta-agonists (LABAs), long-acting muscarinic antagonists (LAMAs), and inhaled corticosteroids (ICSs) are inhaled medications used to manage chronic obstructive pulmonary disease (COPD). When two classes of medications are required,
N. Fukuda   +6 more
semanticscholar   +1 more source

Lama guanicoe

CABI Compendium, 2022
This datasheet on Lama guanicoe covers Identity, Distribution.

semanticscholar   +1 more source

LAMA

Proceedings of the 56th Annual Design Automation Conference 2019, 2019
To satisfy increasing computing demands, heterogeneous computing platforms are gaining attention, especially CPU-FPGA platforms. Recently, emerging tightly coupled CPU-FPGA platforms with shared coherent caches (such as the Intel HARP and IBM POWER with CAPI) have been proposed to facilitate data communication and simplify the programming model.
Liang Feng   +4 more
openaire   +2 more sources

Evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies

Expert Review of Respiratory Medicine, 2020
Objectives In some studies comparing triple with dual combination therapies in COPD there might be a possible effect of inhaler bias resulting from different inhaler devices being used in comparator arms.
L. Calzetta   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy